This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
HK$2,957
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
P/S ratio for Abiomed (ABMD)
P/S ratio on August 1, 2024 (TTM) : 16.0
According to Abiomed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.2. At the end of 2022 the company had a P/S ratio of 10.4.
P/S ratio history for Abiomed from 2014 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 10.4 | -36.17% |
| 2021 | 16.3 | -9.61% |
| 2020 | 18.0 | 97.01% |
| 2019 | 9.15 | -53.98% |
| 2018 | 19.9 | 30.49% |
| 2017 | 15.2 | 29.19% |
| 2016 | 11.8 | -6.71% |
| 2015 | 12.6 | 72.33% |
| 2014 | 7.33 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.98 | -87.61% | 🇺🇸 USA |
 | 8.55 | -46.57% | 🇺🇸 USA |
 | 3.52 | -77.99% | 🇺🇸 USA |